Session 207: Infectious Complications of Immunomodulatory Biologic Agents: Risk Assessment, Diagnosis, and Management
The IDWeek 2019 Digital Library is intended as a resource to view IDWeek sessions virtually and claim CME credit. If you plan to claim CME credit for a session, please ensure you have first watched the session video in the DIGITAL LIBRARY prior to completing the evaluation form.
Faculty and Disclosures
Kevin Winthrop MD, MPH; Associate Professor Oregon Health & Science University, COI Disclosures: Nothing to disclose
Cassandra Calabrese, DO; Associate Staff Cleveland Clinic Foundation, COI Disclosures: Sanofi-Regeneron: Speaker's Bureau
IDSA is accredited by the Accreditation Council for Continuing Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
IDSA designates this enduring material for a maximum of 25.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 AMA PRA Category 1 Credit(s)™